← Back to Clinical Trials
Recruiting NCT06465290

NCT06465290 Promoting Neuroplastic Changes of Patients With TBI

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06465290
Status Recruiting
Phase
Sponsor University of Maryland, Baltimore
Condition Traumatic Brain Injury
Study Type INTERVENTIONAL
Enrollment 100 participants
Start Date 2026-07-16
Primary Completion 2029-08-31

Eligibility & Interventions

Sex All sexes
Min Age 30 Years
Max Age 85 Years
Study Type INTERVENTIONAL
Interventions
Motor relearning training with wearable ankle robotPassive stretching with wearable ankle robotGamed-based active movement training with wearable ankle robot

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 100 participants in total. It began in 2026-07-16 with a primary completion date of 2029-08-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project will develop a wearable rehabilitation robot suitable for in-bed acute stage rehabilitation. It involves robot-guided motor relearning, passive and active motor-sensory rehabilitation early in the acute stage post-TBI including patients who are paralyzed with no motor output. The early acute TBI rehabilitation device will be evaluated in this clinical trial.

Eligibility Criteria

Inclusion Criteria: * Acute first time unilateral hemispheric stroke (hemorrhagic or ischemic stroke, 24 hours after admission to 1 month post-stroke at the start of the proposed treatment) * Hemiplegia or hemiparesis * 0≤Manual Muscle Testing (MMT)\<=2 * Age 30-85 * Ankle impairments including stiff calf muscles and/or inadequate dorsiflexion Exclusion Criteria: * Medically not stable * Associated acute medical illness that interferes with ability to training and exercise * No impairment or very mild ankle impairment of ankle * Severe cardiovascular problems that interfere with ability to perform moderate movement exercises * Cognitive impairment or aphasia with inability to follow instructions * Severe pain in legs * Severe ankle contracture greater than 15° plantar flexion (when pushing ankle to dorsiflexion) * Pressure ulcer, recent surgical incision or active skin disease with open wounds present below knee

Contact & Investigator

Central Contact

Soh-Hyun Hur

✉ SoHur@som.umaryland.edu

📞 410 706-8625

Principal Investigator

Li-Qun Zhang

PRINCIPAL INVESTIGATOR

University of Maryland

Frequently Asked Questions

Who can join the NCT06465290 clinical trial?

This trial is open to participants of all sexes, aged 30 Years or older, up to 85 Years, studying Traumatic Brain Injury. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06465290 currently recruiting?

Yes, NCT06465290 is actively recruiting participants. Contact the research team at SoHur@som.umaryland.edu for enrollment information.

Where is the NCT06465290 trial being conducted?

This trial is being conducted at Baltimore, United States.

Who is sponsoring the NCT06465290 clinical trial?

NCT06465290 is sponsored by University of Maryland, Baltimore. The principal investigator is Li-Qun Zhang at University of Maryland. The trial plans to enroll 100 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology